1. Home
  2. WSE vs BMRN Comparison

WSE vs BMRN Comparison

Compare WSE & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wise Group plc Class A Ordinary Shares

WSE

Wise Group plc Class A Ordinary Shares

N/A

Current Price

$10.68

Market Cap

12.6B

Sector

Industrials

ML Signal

N/A

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

N/A

Current Price

$61.59

Market Cap

12.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WSE
BMRN
Founded
2010
1996
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.6B
12.3B
IPO Year
2025
1999

Fundamental Metrics

Financial Performance
Metric
WSE
BMRN
Price
$10.68
$61.59
Analyst Decision
Strong Buy
Buy
Analyst Count
14
28
Target Price
$17.01
★ $90.30
AVG Volume (30 Days)
★ 2.4M
2.0M
Earning Date
12-01-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.14
Revenue
N/A
★ $1,313,646,000.00
Revenue This Year
$20.63
$20.01
Revenue Next Year
$16.35
$14.75
P/E Ratio
★ N/A
$426.71
Revenue Growth
N/A
★ 17.62
52 Week Low
$10.56
$49.26
52 Week High
$13.66
$70.98

Technical Indicators

Market Signals
Indicator
WSE
BMRN
Relative Strength Index (RSI) 41.74 65.51
Support Level N/A $58.03
Resistance Level $13.37 $66.95
Average True Range (ATR) 0.35 2.13
MACD 0.01 0.68
Stochastic Oscillator 8.21 83.96

Price Performance

Historical Comparison
WSE
BMRN

About WSE Wise Group plc Class A Ordinary Shares

Wise is a currency conversion platform that matches, where possible, offsetting currency transactions across borders to reduce costs. The group focuses primarily on private clients and small and midsize enterprises, but it is building out its platform business aimed at providing its services as a backend solution to banks. By operating local accounts in each jurisdiction Wise sends money to or receives money from, this fintech offers faster and cheaper currency transfer services than incumbents (banks). Wise has started to broaden its product offering, issuing its clients debit cards and allowing customers to invest funds in various asset management products.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: